{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-003571","form_type":"8-K","ticker":"FBLG","cik":"0001958777","company_name":"FibroBiologics, Inc.","filed_at":"2025-01-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.649831+00:00","generated_at":"2026-05-27T11:56:53.421838+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"FibroBiologics board approves 2024 incentive bonuses for CEO O'Heeron and other executives","bullets":["CEO Pete O'Heeron received $390,000 non-equity incentive bonus, total compensation $1,805,199 for 2024.","CSO Hamid Khoja received $150,000 bonus, total compensation $853,646.","GC Ruben Garcia (hired March 2024) received $142,188 bonus, total compensation $2,752,843 including option grant.","Interim CFO Robert Hoffman awarded a $75,000 bonus for 2024.","Bonuses were previously undetermined and approved on January 23, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-003571","json":"https://secwatch.observer/filing/0001493152-25-003571.json","markdown":"https://secwatch.observer/filing/0001493152-25-003571.md","text":"https://secwatch.observer/filing/0001493152-25-003571.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1958777/000149315225003571/0001493152-25-003571-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1958777/000149315225003571/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T11:56:53.421838+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}